Shanghai Shen Lian Biomedical Corp
SSE:688098

Watchlist Manager
Shanghai Shen Lian Biomedical Corp Logo
Shanghai Shen Lian Biomedical Corp
SSE:688098
Watchlist
Price: 9.29 CNY 4.62% Market Closed
Market Cap: 3.8B CNY

Shanghai Shen Lian Biomedical Corp
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shanghai Shen Lian Biomedical Corp
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Shen Lian Biomedical Corp
SSE:688098
EPS (Diluted)
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
EPS (Diluted)
ÂĄ0
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
EPS (Diluted)
ÂĄ4
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
EPS (Diluted)
ÂĄ1
CAGR 3-Years
26%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
EPS (Diluted)
ÂĄ2
CAGR 3-Years
25%
CAGR 5-Years
-5%
CAGR 10-Years
1%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
EPS (Diluted)
ÂĄ9
CAGR 3-Years
N/A
CAGR 5-Years
241%
CAGR 10-Years
N/A
No Stocks Found

Shanghai Shen Lian Biomedical Corp
Glance View

Market Cap
3.8B CNY
Industry
Pharmaceuticals

Shanghai Shen Lian Biomedical Corp. engages in the research, development, and manufacture of vaccines for the animal farming industry. The company is headquartered in Shanghai, Shanghai and currently employs 297 full-time employees. The company went IPO on 2019-10-28. The firm is committed to the research & development of foot and mouth disease vaccines, which are used to protect animals from foot and mouth diseases. The firm's main product are swine foot and mouth disease vaccines, and it also provides cattle foot and mouth disease vaccines, other swine vaccines, and other veterinary diagnostic reagents. The firm mainly sells its products within domestic market.

Intrinsic Value
14.93 CNY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Shanghai Shen Lian Biomedical Corp's EPS (Diluted)?
EPS (Diluted)
-0.1 CNY

Based on the financial report for Dec 31, 2024, Shanghai Shen Lian Biomedical Corp's EPS (Diluted) amounts to -0.1 CNY.

Back to Top